drugset / Trial / NCT00132730
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a study to evaluate the effectiveness and tolerability of a once-daily oral medication (MK-0873) for the treatment of COPD (chronic obstructive pulmonary disease) to determine whether the study drug leads to an improvement in pulmonary (lung) function, as well as symptoms, and quality of life.
Timeline
- Start
- 2004-06-01
- Primary completion
- 2005-08-17
- Completion
- 2005-08-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-0873 | Small molecule | 0.75 mg | Oral |
| Subject | MK-0873 | Small molecule | 1.25 mg | Oral |
| Subject | MK-0873 | Small molecule | 2.5 mg | Oral |